Medical/Pharmaceuticals
CETAPHIL OPTIMAL HYDRATION COMBATS DRY, DEHYDRATED AND SENSITIVE SKIN
* Introducing Cetaphil Optimal Hydration, a Hydration Skin Care line that delivers lasting 48-hours hydration KUALA LUMPUR, Malaysia, April 8, 2022 /PRNewswire/ -- Cetaphil is known for its long and proven record of providing skincare solutions with strong dermatological and medical heritage. D...
2022-04-08 16:27
4860
New very-high-sensitivity rapid antigen test kits hit Australian market
New COVID-19 Medriva Rapid Antigen Test kits with very high- sensitivity now
available inAustralia
MELBOURNE, Australia, April 8, 2022 /PRNewswire/ -- Medriva;
https://medriva.com
2022-04-08 06:00
3810
Henlius' Serplulimab Granted Orphan-Drug Designation in the United States for Small Cell Lung Cancer
SHANGHAI, April 7, 2022 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the United States Food and Drug Administration (FDA) has granted Orphan-Drug Designation (ODD) for HANSIZHUANG (serplulimab) for the treatment of small cell lung cancer (SCLC). This is the first such d...
2022-04-07 22:21
4417
SIMCERE PHARMA (HK.2096) to host 2022 R&D Day
HONG KONG, April 7, 2022 /PRNewswire/ -- SIMCERE PHARMA (HK.2096), an innovation and R&D-driven pharmaceutical company with a mission of "providing today's patients with medicines of the future", will host a virtual R&D Day, on Friday,15 April, 2022, at 21:00-23:00 (HKT) / 9:00-11:00 (EST) / 13:0...
2022-04-07 21:39
3469
Contract Development and Manufacturing Organizations Shifting Focus to Meet Future Demand
An integrated and agile approach enables the pharmaceutical CDMO industry to simplify manufacturing as it moves from primary care medicines to specialty medicines SAN ANTONIO, April 7, 2022 /PRNewswire/ -- Transformational forces are influencing the global contract development and manufacturing ...
2022-04-07 18:01
1974
Asset Visibility Market Opportunity in the Pharmaceutical Industry Worth US$2.7 Billion by 2026
IoT technologies contribute to rapidly expanding market for safeguarding goods as well as improving enterprises' bottom line LONDON, April 7, 2022 /PRNewswire/ -- Pharmaceutical manufacturers, distributors, and transportation providers all face unique pain points within their supply chain operat...
2022-04-07 16:00
2222
Therapy Pro wins at the 2022 Australian Disability Service Awards
* Therapy Pro has been recognised at the Australian Disability Service Awards for their innovative program offerings and positive exceptional outcomes. * Claiming "Best Early Intervention Program", the award was received by Managing DirectorPhil Laidlaw. * The Australian Disability Awards sa...
2022-04-07 12:33
2918
Rona Therapeutics Announces Completion of $33 Million Series A Financing to Advance Global Discovery and Development of RNA Therapeutics
- Funding from long-term investors to build leading delivery platform and scalable drug discovery engine to enable modular and programmable medicines - Company is harnessing the potential of RNA therapeutics to deliver medicines to liver and extrahepatic tissues with specific, stable and prolonge...
2022-04-07 12:30
4370
BIO KOREA, Asia's Biggest Bio-Health Convention, to Open in May 2022
Global Event to Kick off as the Post-COVID Era Begins in Earnest, with Theme "Beyond the Pandemic, into a Next Wave" SEOUL, South Korea, April 7, 2022 /PRNewswire/ --Initiated in 2006, BIO KOREA is the biggest bio-health convention inAsia that is dedicated to promoting the international standin...
2022-04-07 10:14
5351
Everest Medicines Enters into an MOU for Partnership with China Resources Pharmaceutical Group for its mRNA Vaccine Business
China Resources Pharmaceutical Group ("CR Pharma") intends to make strategic equity investment for Everest's mRNA technology platform Partnership with CR Pharma will provide local support to navigate China regulatory pathways across mRNA vaccine platform, first in the advancement of Everest's po...
2022-04-07 07:30
5419
ZEISS to Unveil Clinical Insights Supporting the Value of New Data-Driven Digital Workflow Solutions and Software Applications
Advancing ophthalmic care through integrated clinical workflow solutions: * Efficiency in the cataract workflow * Can help increase treatment outcome predictability in the corneal refractive workflow * Machine learning and artificial intelligence in the retina clinic JENA, Germany and DUBLI...
2022-04-06 21:00
2966
Treadwell Therapeutics and University Health Network Sign Licensing Agreement for pre-clinical biologic and small molecule assets
NEW YORK, HONG KONG and TORONTO, April 6, 2022 /PRNewswire/ -- Treadwell Therapeutics today announced that it has entered into a license agreement with the University Health Network (UHN) inToronto, Canada for four novel oncology target programs, including a deep estate of pre-clinical therapeuti...
2022-04-06 20:59
2534
Seegene's Allplex™ RV Master Assay receives Australian TGA approval, European CE-IVD mark
* Test detects 21 targets for 19 respiratory viruses in single tube, including COVID-19 and flu * Assay result of Seegene's decades-long know-how, applies DPO∙TOCE∙MuDT technologies * "Optimal solution for safe return to normalcy as distancing restrictions eased" SEOUL, South Korea, April 6...
2022-04-06 20:08
2992
Antengene's Pivotal "MARCH" Study to Evaluate Selinexor (ATG-010) in Relapsed or Refractory Multiple Myeloma Published in BMC Medicine
- Results showed an overall response rate (ORR) of 29.3% for all treated patients. - Consistent responses across all risk groups, including patients who received prior "triple-class" and CAR-T therapies or having cytogenetic abnormalities. - Selinexor is on track for a Q2:22 launch in China. SHAN...
2022-04-06 20:03
4701
Ceres Nanosciences Establishes Sixteen Wastewater-Based Epidemiology Centers of Excellence Under NIH RADx Initiative
MANASSAS, Va., April 6, 2022 /PRNewswire/ -- Ceres Nanosciences (Ceres), a privately held company that makes innovative products to improve life science research and diagnostic testing, is announcing the establishment of six new wastewater-based epidemiology centers of excellence. The new centers...
2022-04-06 19:37
4180
Ascletis Announces China IND Approval of Its Second FASN Inhibitor ASC60 for Treatment of Advanced Solid Tumors
HANGZHOU, China and SHAOXING, China, April 6, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) today announces that the Investigational New Drug (IND) application of its second fatty acid synthase (FASN) inhibitor ASC60 for treatment of advanced solid tumors has been approved by China ...
2022-04-06 17:10
5048
PSMA-PET Imaging to be Funded through Medicare in Australia from July 2022
MELBOURNE, Australia, April 6, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) welcomes the listing of prostate-specific membrane antigen (PSMA) positron emission tomography (PET) (PSMA-PET) imaging for patients with prostate cancer on the Medicare Benefits Sche...
2022-04-06 12:47
4053
Innovent Announces the Approval of Pemazyre® (pemigatinib) by the NMPA for the Treatment of Adults with Locally Advanced or Metastatic Cholangiocarcinoma with A FGFR2 Fusion or Rearrangement As Confirmed By A Validated Diagnostic Test That Have Progressed After at Least One Prior Line of Systemic Therapy
SAN FRANCISCO and SUZHOU, China, April 6, 2022 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major disea...
2022-04-06 12:43
4636
VISTA Eye Specialist (VISTA) introduces cutting-edge Swiss Technology for Cataract Surgery, giving patients a simple, fast and safe procedure.
PETALING JAYA, Malaysia, April 6, 2022 /PRNewswire/ -- VISTA is always looking to provide the latest technology availablefor Cataract patients - making the surgery simpler and improve the result, safety and comfort - not just for the patient but also the surgeon. Having Robotic Computer-aided tec...
2022-04-06 09:11
3644
Cambridge Nutranostics has developed a point-of-care prototype of OCCL test for testing blood plasma oxygen to monitor health in post stroke and TIA patients for dementia prevention
CAMBRIDGE, England, April 6, 2022 /PRNewswire/ -- Cambridge Nutranostics Ltd,
CNL,http://occltest.com
2022-04-06 09:00
2272
Week's Top Stories
Most Reposted
SALMON SECURES $140 MILLION (PHP 8.8 BILLION) TO DOUBLE DOWN ON THE GROWTH OPPORTUNITY IN THE PHILIPPINES
[Picked up by 282 media titles]
2026-10-19 13:18
Infobip and Yamaha Power Conversational Customer Engagement in Indonesia's Automotive Sector
[Picked up by 275 media titles]
2026-10-21 15:00
DayOne Supports NVIDIA DSX POD Reference Design, Advancing Standardized Infrastructure for AI
[Picked up by 270 media titles]
2026-10-22 11:55Carro Establishes Inaugural SGD450 Million Asset-Backed Securitisation Warehouse Facility
[Picked up by 267 media titles]
2026-10-22 11:00Ready Server Launches ReadyServer LLM API, Giving Every VPS Customer Private AI Inference at No Extra Cost
[Picked up by 265 media titles]
2026-10-20 14:10Most Read
Home 3D Printers are More Accessible Than Ever This Black Friday with Bambu Lab
2026-10-22 17:00
14737
SALMON SECURES $140 MILLION (PHP 8.8 BILLION) TO DOUBLE DOWN ON THE GROWTH OPPORTUNITY IN THE PHILIPPINES
2026-10-19 13:18
12082
FinDev Canada provides a USD 60 million loan to Muangthai Capital to advance gender equality and private sector investment in Thailand
2026-10-17 00:54
12000
BUUU Group Limited Announces 10-for-1 Forward Share Split
2026-10-17 04:30
11371